Zhiqiang Wu

11PUBLICATIONS

22CO-AUTHORS

Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisCancer cell biologyPhotogrammetry and remote sensing

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (11)

Sort by Publication Date:

|May 18, 2026

DNA-PK-mediated CRTC2 phosphorylation promotes NHEJ and suppresses antitumor immunity via relocation to repair complexes.

|Nov 25, 2025

The deubiquitinase OTUD1 orchestrates cisplatin chemosensitivity of non-small cell lung cancer through destabilizing RAD23B/XPC.

Zhiqiang Wu, Meixi Wang, Xiaohan Dong

|Aug 23, 2025

CAD hijacks STING to impair antitumor immunity and radiotherapy efficacy of colorectal cancer.

Zhengkun Cai, Zeyuan Cheng, Lu Zhang

|Mar 04, 2025

CRTC2 Forms Co-Condensates with YTHDF2 That Enhance Translational Efficiency of m6A-Modified mRNAs to Drive Hepatocarcinogenesis and Lenvatinib Resistance.

Meixi Wang, Fangdi Zou, Shengxin Wang

|Jun 28, 2024

MicroRNA-384 radiosensitizes human non-small cell lung cancer by impairing DNA damage response and repair signaling, which is inhibited by NF-κB.

Yanchen Sun, Jing Wang, Minghan Qiu

|Feb 23, 2023

SPATA2 suppresses epithelial-mesenchymal transition to inhibit metastasis and radiotherapy sensitivity in non-small cell lung cancer via impairing DVL1/β-catenin signaling.

Hongbo Ji, Lu Zhang, Man Zou

Pageof 2

Frequent Collaborators

Zeyun Mi

Zhiyong Yuan

Fangdi Zou

Kexin Chen

Meixi Wang

Shengxin Wang

Yichen Yang

Cong Xia

Lei Shi

Ben Liu

Frequent Collaborators

Zeyun Mi

Zhiyong Yuan

Fangdi Zou

Kexin Chen